PhRMA's new report counts each cancer drug in the US pipeline, which has now swelled to over 1,000 in the clinic - endpts.com/phrmas-new-rep…

There are 2,004 cancer immunotherapies crowding into the pipeline. Now what? - endpts.com/there-are-2004…

Today $LCTX announced positive additional results from an ongoing Phase I/IIa study of OpRegen, a therapy currently in development for the treatment of #dryAMD at #AAO2019. Listen below as CEO Brian Culley discusses the impact of these results. Read more: investor.lineagecell.com/news-releases/…

NanOlogy LLC will be at #ACG2019 with presentations of data on intramural delivery of NanoPac® for #pancreaticcancer. Oct 28/29 in #SanAntonio. Details: acgmeetings.gi.org/annual-meeting/

"We're targeting #medicine at the molecular makeup, not at the diagnostic label of the tumour." Check out this interview with our CEO, Steve Gardner (Steve Gardner), courtesy of @singular_talent. anchor.fm/careers-in-dis… #pharma #biotech #drugdiscovery

At Discovery Park, we don’t just work to make today a success, we’re always looking to tomorrow. #STEM education is a vital part of what we do, sparking a love of #science to last a lifetime. Learn more about #education discovery-park.co.uk/education/

Over half of all anti-vaccine ads on #Facebook stem from just two advertisers bit.ly/32RhYct #pharma #vaccines

Fantastic discussion yesterday at #BioMedInnovate on what Canada's #biomedical sector needs to facilitate large-scale #commercialization & a thriving #ecosystem with @bloomburton, Lumira Ventures @NovoNordiskCA & Zymeworks Inc. brilliantly moderated by Sean Silcoff Globe and Mail Events

Check out my latest article: Top 400 Immuno-Oncology Startups - Key Technologies, Pipeline, Deals and Funding Analysis linkedin.com/pulse/top-400-… via LinkedIn

Top 400 Immuno-Oncology Startups - Key Technologies, Pipeline, Deals and Funding Analysis linkedin.com/pulse/top-400-… via LinkedIn

Top 400 Immuno-Oncology Startups – Key Technologies, Pipeline, Deals and Funding Analysis. omicsx.com/top-400-immuno…

Global Top 370 Neurology Startups – Key Technologies, Pipeline, Deals and Funding. Early stage pipeline for Alzheimer’s Disease, Parkinson Disease, Pain Treatment, Multiple Sclerosis, Epilepsy, Ischemic Stroke & Traumatic Brain Injury and Schizophrenia. omicsx.com/global-top-370…

Global Top 400 Immuno-Oncology Startups – Key Technologies, Pipeline, De... youtu.be/Py4yzO6My94 via YouTube

ImmunoOncology 2020 is available at $199 USD only. Promotion + Charity @ Next 48 Hrs - our year end agenda -linkedin.com/pulse/promotio… via LinkedIn

Banking stem cells is acquiring and storing your stem cells in a safe place so when you need them, they are ready for your withdrawal. #StemCells #HopeBiosciences #HTX #HopeBio #NotAllStemCellsAreCreatedEqual #RegenerativeMedicine #Innovation #Biotechnology #CellTherapy #Science

Strategic Business Development Services OmicsX - Innovation Insights youtu.be/VouUplJAlZo Day to Day basis provide complete insights on new emerging leads matches your business offerings thus keep your BD team a step ahead in first to introduce your service offerings to your future new clients.

Oncology Drug Development in Europe - A Snapshot linkedin.com/pulse/oncology…

Cancer Targeting Molecules in Active Development in Europe - 2024 linkedin.com/pulse/cancer-t…

From ADCs to DACs: Why Catalytic Payloads Are the Next Turn in Oncology Biologics linkedin.com/pulse/from-adc…